Mycovia Pharms Drug Patent Portfolio
Mycovia Pharms owns 1 orange book drug protected by 5 US patents Given below is the list of Mycovia Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10414751 | Antifungal compounds and processes for making | 17 Mar, 2036 | Active |
| US9840492 | Antifungal compounds and processes for making | 17 Mar, 2036 | Active |
| US11247981 | Metalloenzyme inhibitor compounds | 09 May, 2033 | Active |
| US8236962 | Metalloenzyme inhibitor compounds | 22 Apr, 2031 | Active |
| US8754227 | Metalloenzyme inhibitor compounds | 22 Apr, 2031 | Active |
Latest Legal Activities on Mycovia Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Mycovia Pharms.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Recordation of Patent eCertificate of Correction | 05 Mar, 2024 | US11247981 |
|
Email Notification
Critical
| 05 Mar, 2024 | US11247981 |
| Patent eCofC Notification | 05 Mar, 2024 | US11247981 |
| Mail Patent eCofC Notification | 05 Mar, 2024 | US11247981 |
| Post Issue Communication - Certificate of Correction | 15 Feb, 2024 | US11247981 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 07 Feb, 2024 | US8236962 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 17 Mar, 2023 | US10414751 |
| Initial letter Re: PTE Application to regulating agency | 08 Jul, 2022 | US8236962 |
| Post Issue Communication - Certificate of Correction | 12 May, 2022 | US11247981 |
|
Recordation of Patent Grant Mailed
Critical
| 15 Feb, 2022 | US11247981 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 15 Feb, 2022 | US11247981 |
|
Email Notification
Critical
| 27 Jan, 2022 | US11247981 |
|
Issue Notification Mailed
Critical
| 26 Jan, 2022 | US11247981 |
| Dispatch to FDC | 06 Jan, 2022 | US11247981 |
|
Application Is Considered Ready for Issue
Critical
| 06 Jan, 2022 | US11247981 |
Mycovia Pharms's Family Patents
Mycovia Pharms Drug List
Given below is the complete list of Mycovia Pharms's drugs and the patents protecting them.
1. Vivjoa
Vivjoa is protected by 5 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10414751 | Antifungal compounds and processes for making |
17 Mar, 2036
(10 years from now)
| Active |
| US9840492 | Antifungal compounds and processes for making |
17 Mar, 2036
(10 years from now)
| Active |
| US11247981 | Metalloenzyme inhibitor compounds |
09 May, 2033
(8 years from now)
| Active |
| US8236962 | Metalloenzyme inhibitor compounds |
22 Apr, 2031
(5 years from now)
| Active |
| US8754227 | Metalloenzyme inhibitor compounds |
22 Apr, 2031
(5 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Vivjoa's drug page